82 related articles for article (PubMed ID: 18800767)
1. Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity.
Chao EY; Caravella JA; Watson MA; Campobasso N; Ghisletti S; Billin AN; Galardi C; Wang P; Laffitte BA; Iannone MA; Goodwin BJ; Nichols JA; Parks DJ; Stewart E; Wiethe RW; Williams SP; Smallwood A; Pearce KH; Glass CK; Willson TM; Zuercher WJ; Collins JL
J Med Chem; 2008 Sep; 51(18):5758-65. PubMed ID: 18800767
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of liver X receptors by acanthoic acid-related diterpenes.
Traves PG; Hortelano S; Zeini M; Chao TH; Lam T; Neuteboom ST; Theodorakis EA; Palladino MA; Castrillo A; Bosca L
Mol Pharmacol; 2007 Jun; 71(6):1545-53. PubMed ID: 17329499
[TBL] [Abstract][Full Text] [Related]
3. Carboxylic acid based quinolines as liver X receptor modulators that have LXRbeta receptor binding selectivity.
Hu B; Quinet E; Unwalla R; Collini M; Jetter J; Dooley R; Andraka D; Nogle L; Savio D; Halpern A; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J
Bioorg Med Chem Lett; 2008 Jan; 18(1):54-9. PubMed ID: 18023179
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic opportunities for liver X receptor modulators.
Collins JL
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
[TBL] [Abstract][Full Text] [Related]
5. 2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.
Kher S; Lake K; Sircar I; Pannala M; Bakir F; Zapf J; Xu K; Zhang SH; Liu J; Morera L; Sakurai N; Jack R; Cheng JF
Bioorg Med Chem Lett; 2007 Aug; 17(16):4442-6. PubMed ID: 17587573
[TBL] [Abstract][Full Text] [Related]
6. Discovery of tertiary sulfonamides as potent liver X receptor antagonists.
Zuercher WJ; Buckholz RG; Campobasso N; Collins JL; Galardi CM; Gampe RT; Hyatt SM; Merrihew SL; Moore JT; Oplinger JA; Reid PR; Spearing PK; Stanley TB; Stewart EL; Willson TM
J Med Chem; 2010 Apr; 53(8):3412-6. PubMed ID: 20345102
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production.
Fowler AJ; Sheu MY; Schmuth M; Kao J; Fluhr JW; Rhein L; Collins JL; Willson TM; Mangelsdorf DJ; Elias PM; Feingold KR
J Invest Dermatol; 2003 Feb; 120(2):246-55. PubMed ID: 12542530
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of novel transrepression-selective liver X receptor (LXR) ligands with 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one skeleton.
Aoyama A; Endo-Umeda K; Kishida K; Ohgane K; Noguchi-Yachide T; Aoyama H; Ishikawa M; Miyachi H; Makishima M; Hashimoto Y
J Med Chem; 2012 Sep; 55(17):7360-77. PubMed ID: 22873709
[TBL] [Abstract][Full Text] [Related]
9. Further modification on phenyl acetic acid based quinolines as liver X receptor modulators.
Hu B; Jetter J; Kaufman D; Singhaus R; Bernotas R; Unwalla R; Quinet E; Savio D; Halpern A; Basso M; Keith J; Clerin V; Chen L; Liu QY; Feingold I; Huselton C; Azam F; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J
Bioorg Med Chem; 2007 May; 15(10):3321-33. PubMed ID: 17391964
[TBL] [Abstract][Full Text] [Related]
10. LXR agonists for the treatment of atherosclerosis.
Jaye M
Curr Opin Investig Drugs; 2003 Sep; 4(9):1053-8. PubMed ID: 14582448
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of anilinohexafluoroisopropanols as activators/modulators of LXRalpha and beta.
Panday N; Benz J; Blum-Kaelin D; Bourgeaux V; Dehmlow H; Hartman P; Kuhn B; Ratni H; Warot X; Wright MB
Bioorg Med Chem Lett; 2006 Oct; 16(19):5231-7. PubMed ID: 16876993
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor and farnesoid X receptor as therapeutic targets.
Rader DJ
Am J Cardiol; 2007 Dec; 100(11 A):n15-9. PubMed ID: 18047847
[TBL] [Abstract][Full Text] [Related]
13. 4-(3-aryloxyaryl)quinoline alcohols are liver X receptor agonists.
Bernotas RC; Kaufman DH; Singhaus RR; Ullrich J; Unwalla R; Quinet E; Nambi P; Wilhelmsson A; Goos-Nilsson A; Wrobel J
Bioorg Med Chem; 2009 Dec; 17(23):8086-92. PubMed ID: 19853462
[TBL] [Abstract][Full Text] [Related]
14. Structural development of liver X receptor (LXR) antagonists derived from thalidomide-related glucosidase inhibitors.
Noguchi-Yachide T; Miyachi H; Aoyama H; Aoyama A; Makishima M; Hashimoto Y
Chem Pharm Bull (Tokyo); 2007 Dec; 55(12):1750-4. PubMed ID: 18057753
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma.
Chao EY; Collins JL; Gaillard S; Miller AB; Wang L; Orband-Miller LA; Nolte RT; McDonnell DP; Willson TM; Zuercher WJ
Bioorg Med Chem Lett; 2006 Feb; 16(4):821-4. PubMed ID: 16307879
[TBL] [Abstract][Full Text] [Related]
16. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
[TBL] [Abstract][Full Text] [Related]
17. Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development.
Dodo K; Aoyama A; Noguchi-Yachide T; Makishima M; Miyachi H; Hashimoto Y
Bioorg Med Chem; 2008 Apr; 16(8):4272-85. PubMed ID: 18343126
[TBL] [Abstract][Full Text] [Related]
18. Induced fit in liver X receptor beta: a molecular dynamics-based investigation.
Beautrait A; Karaboga AS; Souchet M; Maigret B
Proteins; 2008 Aug; 72(3):873-82. PubMed ID: 18275080
[TBL] [Abstract][Full Text] [Related]
19. Guttiferone I, a new prenylated benzophenone from Garcinia humilis as a liver X receptor ligand.
Herath K; Jayasuriya H; Ondeyka JG; Guan Z; Borris RP; Stijfhoorn E; Stevenson D; Wang J; Sharma N; Macnaul K; Menke JG; Ali A; Schulman MJ; Singh SB
J Nat Prod; 2005 Apr; 68(4):617-9. PubMed ID: 15844964
[TBL] [Abstract][Full Text] [Related]
20. Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators.
Nomura S; Endo-Umeda K; Aoyama A; Makishima M; Hashimoto Y; Ishikawa M
ACS Med Chem Lett; 2015 Aug; 6(8):902-7. PubMed ID: 26288691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
